276 related articles for article (PubMed ID: 32596075)
61. Tumour lysis syndrome and acute kidney injury in high-risk haematology patients in the rasburicase era. A prospective multicentre study from the Groupe de Recherche en Réanimation Respiratoire et Onco-Hématologique.
Darmon M; Vincent F; Camous L; Canet E; Bonmati C; Braun T; Caillot D; Cornillon J; Dimicoli S; Etienne A; Galicier L; Garnier A; Girault S; Hunault-Berger M; Marolleau JP; Moreau P; Raffoux E; Recher C; Thiebaud A; Thieblemont C; Azoulay E;
Br J Haematol; 2013 Aug; 162(4):489-97. PubMed ID: 23772757
[TBL] [Abstract][Full Text] [Related]
62. Efficacy and cost of single-dose rasburicase in prevention and treatment of adult tumour lysis syndrome: a meta-analysis.
Feng X; Dong K; Pham D; Pence S; Inciardi J; Bhutada NS
J Clin Pharm Ther; 2013 Aug; 38(4):301-8. PubMed ID: 23550846
[TBL] [Abstract][Full Text] [Related]
63. Tumour lysis syndrome.
Calvo Villas JM
Med Clin (Barc); 2019 May; 152(10):397-404. PubMed ID: 30612747
[TBL] [Abstract][Full Text] [Related]
64. Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model.
Montesinos P; Lorenzo I; Martín G; Sanz J; Pérez-Sirvent ML; Martínez D; Ortí G; Algarra L; Martínez J; Moscardó F; de la Rubia J; Jarque I; Sanz G; Sanz MA
Haematologica; 2008 Jan; 93(1):67-74. PubMed ID: 18166787
[TBL] [Abstract][Full Text] [Related]
65. The analysis of the risks for the development of tumour lysis syndrome in children.
Kopecna L; Dolezel Z; Osvaldova Z; Starha J; Hrstkova H
Bratisl Lek Listy; 2002; 103(6):206-9. PubMed ID: 12448566
[TBL] [Abstract][Full Text] [Related]
66. Acute spontaneous tumor lysis syndrome in a patient with Crohn's disease taking immunosuppressants.
Froilán Torres C; Castro Carbajo P; Pajares Villarroya R; Plaza Santos R; Gómez Senent S; Martín Arranz MD; Adán Merino L; Martín Arranz E; Manceñido Marcos N; Peces R; Benito López D
Rev Esp Enferm Dig; 2009 Apr; 101(4):288-94. PubMed ID: 19492906
[TBL] [Abstract][Full Text] [Related]
67. Spontaneous tumor lysis syndrome in adrenal adenocarcinoma: a case report and review of the literature.
Shafie M; Teymouri A; Parsa S; Sadeghian A; Zarei Jalalabadi N
J Med Case Rep; 2022 Feb; 16(1):52. PubMed ID: 35139902
[TBL] [Abstract][Full Text] [Related]
68. Role of i.v. allopurinol and rasburicase in tumor lysis syndrome.
Holdsworth MT; Nguyen P
Am J Health Syst Pharm; 2003 Nov; 60(21):2213-22; quiz 2223-4. PubMed ID: 14619112
[TBL] [Abstract][Full Text] [Related]
69. Febuxostat for management of tumor lysis syndrome including its effects on levels of purine metabolites in patients with hematological malignancies - a single institution's, pharmacokinetic and pilot prospective study.
Takai M; Yamauchi T; Ookura M; Matsuda Y; Tai K; Kishi S; Yoshida A; Iwasaki H; Nakamura T; Ueda T
Anticancer Res; 2014 Dec; 34(12):7287-96. PubMed ID: 25503162
[TBL] [Abstract][Full Text] [Related]
70. Benefit of continuous kidney replacement therapy for managing tumor lysis syndrome in children with hematologic malignancies.
Anderson A; Shoulders L; James V; Ashcraft E; Cheng C; Ribeiro R; Elbahlawan L
Front Oncol; 2023; 13():1234677. PubMed ID: 37664024
[TBL] [Abstract][Full Text] [Related]
71. Acute tumor lysis syndrome in a 7-month-old with hepatoblastoma.
Bercovitz RS; Greffe BS; Hunger SP
Curr Opin Pediatr; 2010 Feb; 22(1):113-6. PubMed ID: 19926992
[TBL] [Abstract][Full Text] [Related]
72. Risk-based management strategy and outcomes of tumor lysis syndrome in children with leukemia/lymphoma: Analysis from a resource-limited setting.
Gopakumar KG; Seetharam S; Km JK; Nair M; Rajeswari B; Cs G; Vr P; Thankamony P
Pediatr Blood Cancer; 2018 Dec; 65(12):e27401. PubMed ID: 30101454
[TBL] [Abstract][Full Text] [Related]
73. Spontaneous Tumor Lysis Syndrome: A Case Report and Critical Evaluation of Current Diagnostic Criteria and Optimal Treatment Regimens.
Weeks AC; Kimple ME
J Investig Med High Impact Case Rep; 2015; 3(3):2324709615603199. PubMed ID: 26904699
[TBL] [Abstract][Full Text] [Related]
74. Tumor lysis syndrome: risk factors, diagnosis, and management.
Burns RA; Topoz I; Reynolds SL
Pediatr Emerg Care; 2014 Aug; 30(8):571-6; quiz 577-9. PubMed ID: 25098804
[TBL] [Abstract][Full Text] [Related]
75. Spontaneous tumor lysis syndrome in patients with solid tumors: a scoping review of the literature.
Papapanou M; Athanasopoulos AE; Georgiadi E; Maragkos SA; Liontos M; Ziogas DC; Damaskos D; Schizas D
Med Oncol; 2023 Jul; 40(8):233. PubMed ID: 37432468
[TBL] [Abstract][Full Text] [Related]
76. Concurrent acute spontaneous tumor lysis syndrome complicated with multiple organ failure in a patient with pre-existing undiagnosed lung cancer.
Amiri FS
CEN Case Rep; 2015 Nov; 4(2):233-237. PubMed ID: 28509107
[TBL] [Abstract][Full Text] [Related]
77. Tumor Lysis Syndrome following a Single Dose of Nivolumab for Relapsed Small-Cell Lung Cancer.
Hayes SM; Wiese C; Schneidewend R
Case Rep Oncol; 2021; 14(3):1652-1659. PubMed ID: 35082621
[TBL] [Abstract][Full Text] [Related]
78. When the Tumor Lyses: A Case Report on Spontaneous Tumor Lysis Syndrome.
Dong J; Cao T; Tanner N; Kundranda M
Case Rep Oncol; 2020; 13(2):979-984. PubMed ID: 32999659
[TBL] [Abstract][Full Text] [Related]
79. Optimizing management of tumor lysis syndrome in adults with hematologic malignancies.
Michallet AS; Tartas S; Coiffier B
Support Cancer Ther; 2005 Apr; 2(3):159-66. PubMed ID: 18628166
[TBL] [Abstract][Full Text] [Related]
80. Tumor Lysis Syndrome after Combination Therapy of Nivolumab and Sorafenib in a Woman with Advanced Hepatocellular Carcinoma.
Yen TH; Chang CH; Shiu SI
Case Rep Gastroenterol; 2020; 14(2):367-372. PubMed ID: 32884512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
